CD8A and neoplasm: Opto-CRAC expressed in DCs could photoinduce Ca2+ influx, promote tumor antigen cross presentation to CD8+ T cells, and boost antitumor immune response both in vitro and in a mouse model of melanoma (FIGURE 6A) (22).